S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
NASDAQ:MGLN

Magellan Health Stock Forecast, Price & News

$94.99
0.00 (0.00%)
(As of 01/4/2022)
Add
Compare
Today's Range
$94.99
$94.99
50-Day Range
$94.25
$94.99
52-Week Range
$91.04
$99.36
Volume
N/A
Average Volume
238,670 shs
Market Capitalization
$2.50 billion
P/E Ratio
8.28
Dividend Yield
N/A
Beta
1.03
30 days | 90 days | 365 days | Advanced Chart
Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for Magellan Health and its competitors with MarketBeat's FREE daily newsletter.


Magellan Health logo

About Magellan Health

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Managed Health Care
Sector
Medical
Current Symbol
NASDAQ:MGLN
CUSIP
55907920
Employees
9,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$5.57 per share
Book Value
$73.03 per share

Profitability

Net Income
$382.33 million
Pretax Margin
-0.08%

Debt

Price-To-Earnings

Miscellaneous

Free Float
22,619,000
Market Cap
$2.50 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/05/2021
Today
1/25/2022
Next Earnings (Estimated)
2/25/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.98 out of 5 stars

Medical Sector

658th out of 1,415 stocks

Hospitals Industry

6th out of 8 stocks

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -












Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

How has Magellan Health's stock been impacted by COVID-19 (Coronavirus)?

Magellan Health's stock was trading at $53.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MGLN shares have increased by 76.3% and is now trading at $94.99.
View which stocks have been most impacted by COVID-19
.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release its next quarterly earnings announcement on Friday, February 25th 2022.
View our earnings forecast for Magellan Health
.

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) released its earnings results on Friday, November, 5th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.34. The firm earned $1.25 billion during the quarter, compared to the consensus estimate of $1.21 billion. Magellan Health had a net margin of 6.26% and a trailing twelve-month return on equity of 1.81%. The business's revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.08 EPS.
View Magellan Health's earnings history
.

Who are Magellan Health's key executives?

Magellan Health's management team includes the following people:
  • Kenneth J. Fasola, Chief Executive Officer & Director
  • James E. Murray, President & Chief Operating Officer
  • David Patrick Bourdon, Chief Financial Officer
  • Caroline Carney, Chief Medical Officer
  • Jeffrey N. West, Principal Accounting Officer, SVP & Controller

What is Kenneth J. Fasola's approval rating as Magellan Health's CEO?

31 employees have rated Magellan Health CEO Kenneth J. Fasola on Glassdoor.com. Kenneth J. Fasola has an approval rating of 83% among Magellan Health's employees.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer (ET), General Motors (GM), NVIDIA (NVDA), Boeing (BA), Netflix (NFLX), UnitedHealth Group (UNH), Broadcom (AVGO), Mastercard (MA), Ford Motor (F) and Overstock.com (OSTK).

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.07%), Exchange Traded Concepts LLC (0.05%), Crossmark Global Holdings Inc. (0.01%) and Eagle Bay Advisors LLC (0.00%). Company insiders that own Magellan Health stock include James E Murray, Jeffrey N West and Mostafa Kamal.
View institutional ownership trends for Magellan Health
.

Which major investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., and Eagle Bay Advisors LLC.
View insider buying and selling activity for Magellan Health
or view top insider-selling stocks.

Which major investors are buying Magellan Health stock?

MGLN stock was acquired by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, and State of Alaska Department of Revenue.
View insider buying and selling activity for Magellan Health
or or view top insider-buying stocks.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $94.99.

How much money does Magellan Health make?

Magellan Health has a market capitalization of $2.50 billion and generates $4.58 billion in revenue each year. The company earns $382.33 million in net income (profit) each year or $11.47 on an earnings per share basis.

How many employees does Magellan Health have?

Magellan Health employs 9,000 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is www.magellanhealth.com.

Where are Magellan Health's headquarters?

Magellan Health is headquartered at 4801 E. Washington Street, Phoenix AZ, 85034.

How can I contact Magellan Health?

Magellan Health's mailing address is 4801 E. Washington Street, Phoenix AZ, 85034. The company can be reached via phone at (800) 642-1716, via email at [email protected], or via fax at 860-507-1990.


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.